Q9NP95
Gene name |
FGF20 |
Protein name |
Fibroblast growth factor 20 |
Names |
FGF-20 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:26281 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
66-193 (beta-trefoil core) |
Relief mechanism |
|
Assay |
|
Target domain |
66-193 (beta-trefoil core) |
Relief mechanism |
|
Assay |
|
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

2 structures for Q9NP95
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
3F1R | X-ray | 250 A | A/B | 1-211 | PDB |
AF-Q9NP95-F1 | Predicted | AlphaFoldDB |
344 variants for Q9NP95
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
RCV000114397 CA151162 rs587777282 |
113 | V>missing | Renal hypodysplasia/aplasia 2 [ClinVar] | Yes |
ClinGen ClinVar dbSNP |
rs1384485178 | 2 | A>P | No | TOPMed | |
rs1266965416 | 2 | A>V | No | gnomAD | |
rs1456038983 | 3 | P>S | No | TOPMed | |
rs866476790 | 5 | A>S | No | Ensembl | |
rs774980310 | 6 | E>D | No |
TOPMed gnomAD |
|
rs1810201095 | 7 | V>A | No | Ensembl | |
rs1328342914 | 8 | G>A | No | gnomAD | |
rs1236847607 | 8 | G>R | No |
TOPMed gnomAD |
|
rs764133199 | 9 | G>A | No |
ExAC TOPMed gnomAD |
|
rs764133199 | 9 | G>D | No |
ExAC TOPMed gnomAD |
|
rs971587907 | 9 | G>S | No |
TOPMed gnomAD |
|
rs764133199 | 9 | G>V | No |
ExAC TOPMed gnomAD |
|
rs1382423605 | 10 | F>L | No | gnomAD | |
rs1386560941 | 10 | F>Y | No |
TOPMed gnomAD |
|
rs1810200476 | 11 | L>P | No | TOPMed | |
rs761291744 | 13 | G>C | No |
ExAC gnomAD |
|
RCV002009976 rs940371952 |
13 | G>D | No |
ClinVar TOPMed dbSNP gnomAD |
|
rs761291744 | 13 | G>R | No |
ExAC gnomAD |
|
rs940371952 | 13 | G>V | No |
TOPMed gnomAD |
|
rs890122801 | 15 | E>D | No | gnomAD | |
rs563056645 | 16 | G>V | No |
1000Genomes ExAC gnomAD |
|
rs1198490956 | 18 | G>R | No | gnomAD | |
rs774802384 | 19 | Q>R | No |
ExAC TOPMed gnomAD |
|
rs1263989325 | 20 | Q>* | No | gnomAD | |
rs1263989325 | 20 | Q>E | No | gnomAD | |
rs368189425 | 20 | Q>L | No |
ESP ExAC TOPMed gnomAD |
|
rs1810199636 | 21 | V>M | No |
TOPMed gnomAD |
|
rs1810199516 | 22 | G>D | No | Ensembl | |
rs2150437425 | 23 | S>* | No | Ensembl | |
rs1695692722 | 24 | H>N | No | gnomAD | |
rs1201636021 | 24 | H>Q | No | TOPMed | |
rs1321230475 | 26 | L>P | No | gnomAD | |
rs1327787964 | 27 | L>F | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA TOPMed gnomAD |
rs997382058 | 28 | P>L | No |
TOPMed gnomAD |
|
rs1040301036 | 28 | P>T | No |
TOPMed gnomAD |
|
rs1471698032 | 29 | P>A | No |
TOPMed gnomAD |
|
rs936160285 | 29 | P>L | No |
TOPMed gnomAD |
|
rs936160285 | 29 | P>R | No |
TOPMed gnomAD |
|
rs1471698032 | 29 | P>S | No |
TOPMed gnomAD |
|
rs1471698032 | 29 | P>T | No |
TOPMed gnomAD |
|
rs1388551553 | 30 | A>T | No |
TOPMed gnomAD |
|
rs748157916 | 30 | A>V | No |
ExAC TOPMed gnomAD |
|
rs781139228 | 31 | G>A | No |
ExAC TOPMed gnomAD |
|
rs1810198621 | 31 | G>R | No |
TOPMed gnomAD |
|
rs781139228 | 31 | G>V | No |
ExAC TOPMed gnomAD |
|
rs754861005 | 32 | E>* | No |
ExAC TOPMed gnomAD |
|
rs754861005 | 32 | E>K | No |
ExAC TOPMed gnomAD |
|
rs754861005 | 32 | E>Q | No |
ExAC TOPMed gnomAD |
|
rs560178950 | 33 | R>G | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs1333634965 | 33 | R>L | No |
TOPMed gnomAD |
|
rs1333634965 | 33 | R>P | No |
TOPMed gnomAD |
|
rs560178950 | 33 | R>W | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs1374947340 | 34 | P>A | No |
TOPMed gnomAD |
|
rs1374947340 | 34 | P>S | No |
TOPMed gnomAD |
|
RCV000722376 rs1563235398 |
34 | P>T | No |
ClinVar Ensembl dbSNP |
|
rs1253072793 | 35 | P>L | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA TOPMed gnomAD |
rs1253072793 | 35 | P>Q | No |
TOPMed gnomAD |
|
rs1253072793 | 35 | P>R | No |
TOPMed gnomAD |
|
rs1322607102 | 35 | P>S | No |
TOPMed gnomAD |
|
rs1810197668 | 36 | L>P | No |
TOPMed gnomAD |
|
rs1205538550 | 37 | L>P | No |
TOPMed gnomAD |
|
rs1205538550 | 37 | L>Q | No |
TOPMed gnomAD |
|
rs1205538550 | 37 | L>R | No |
TOPMed gnomAD |
|
rs1196466631 | 38 | G>D | No | Ensembl | |
rs1459900849 | 38 | G>R | No | gnomAD | |
rs2150437389 | 39 | E>G | No | Ensembl | |
rs1007752081 | 39 | E>Q | No |
TOPMed gnomAD |
|
rs1341053895 | 40 | R>H | No |
TOPMed gnomAD |
|
rs1341053895 | 40 | R>L | No |
TOPMed gnomAD |
|
rs892902237 | 41 | R>G | No |
TOPMed gnomAD |
|
rs758127072 | 41 | R>S | No |
ExAC gnomAD |
|
rs892902237 | 41 | R>W | No |
TOPMed gnomAD |
|
rs1201801919 | 42 | S>G | No | TOPMed | |
rs1382953827 | 42 | S>I | No |
TOPMed gnomAD |
|
rs917244560 | 42 | S>R | No |
TOPMed gnomAD |
|
rs1382953827 | 42 | S>T | No |
TOPMed gnomAD |
|
rs1455087624 | 43 | A>E | No |
TOPMed gnomAD |
|
rs1455087624 | 43 | A>G | No |
TOPMed gnomAD |
|
rs1054572439 | 43 | A>T | No |
TOPMed gnomAD |
|
rs1304104955 | 44 | A>T | No | gnomAD | |
rs750018995 | 45 | E>A | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs750018995 | 45 | E>G | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs1389722667 | 45 | E>K | No |
TOPMed gnomAD |
|
rs1034419442 | 46 | R>L | No |
1000Genomes TOPMed gnomAD |
|
rs1034419442 | 46 | R>P | No |
1000Genomes TOPMed gnomAD |
|
rs1034419442 | 46 | R>Q | No |
1000Genomes TOPMed gnomAD |
|
rs764839951 | 46 | R>W | No |
ExAC TOPMed gnomAD |
|
rs1429324991 | 47 | S>G | No | gnomAD | |
rs1385984646 | 47 | S>I | No |
TOPMed gnomAD |
|
rs1385984646 | 47 | S>N | No |
TOPMed gnomAD |
|
rs112761348 | 47 | S>R | No |
TOPMed gnomAD |
|
rs1236770327 | 48 | A>G | No |
TOPMed gnomAD |
|
rs1442725564 | 48 | A>P | No |
TOPMed gnomAD |
|
rs1442725564 | 48 | A>S | No |
TOPMed gnomAD |
|
rs1442725564 | 48 | A>T | No |
TOPMed gnomAD |
|
rs1236770327 | 48 | A>V | No |
TOPMed gnomAD |
|
rs1014889171 | 49 | R>C | No |
1000Genomes TOPMed gnomAD |
|
rs1014889171 | 49 | R>G | No |
1000Genomes TOPMed gnomAD |
|
rs768155803 | 49 | R>H | No |
ExAC gnomAD |
|
rs768155803 | 49 | R>L | No |
ExAC gnomAD |
|
rs1014889171 | 49 | R>S | No |
1000Genomes TOPMed gnomAD |
|
rs774926782 | 50 | G>A | No |
ExAC TOPMed gnomAD |
|
rs760057737 | 50 | G>C | No |
ExAC TOPMed gnomAD |
|
rs774926782 | 50 | G>D | No |
ExAC TOPMed gnomAD |
|
rs760057737 | 50 | G>S | No |
ExAC TOPMed gnomAD |
|
rs763286912 | 51 | G>E | No |
ExAC TOPMed gnomAD |
|
rs1354870466 | 51 | G>R | No |
TOPMed gnomAD |
|
rs763286912 | 51 | G>V | No |
ExAC TOPMed gnomAD |
|
rs1354870466 | 51 | G>W | No |
TOPMed gnomAD |
|
rs1337956675 | 52 | P>A | No |
TOPMed gnomAD |
|
rs770019188 | 52 | P>Q | No |
ExAC TOPMed gnomAD |
|
rs770019188 | 52 | P>R | No |
ExAC TOPMed gnomAD |
|
rs1337956675 | 52 | P>S | No |
TOPMed gnomAD |
|
rs557790865 | 53 | G>A | No |
1000Genomes TOPMed gnomAD |
|
rs557790865 | 53 | G>E | No |
1000Genomes TOPMed gnomAD |
|
rs1810195185 | 54 | A>D | No | Ensembl | |
rs544089387 | 54 | A>S | No |
1000Genomes TOPMed gnomAD |
|
rs544089387 | 54 | A>T | No |
1000Genomes TOPMed gnomAD |
|
rs1053462209 | 55 | A>E | No |
1000Genomes TOPMed |
|
rs991685834 | 55 | A>S | No |
TOPMed gnomAD |
|
rs991685834 | 55 | A>T | No |
TOPMed gnomAD |
|
rs748250152 | 56 | Q>H | No |
ExAC TOPMed gnomAD |
|
rs1810194976 | 56 | Q>K | No | TOPMed | |
rs1471106247 | 56 | Q>L | No |
TOPMed gnomAD |
|
rs1471106247 | 56 | Q>P | No |
TOPMed gnomAD |
|
rs1490416114 | 57 | L>P | No | gnomAD | |
rs1181132258 | 57 | L>V | No |
TOPMed gnomAD |
|
rs776625873 | 58 | A>E | No |
ExAC gnomAD |
|
rs1554495374 | 58 | A>S | No | gnomAD | |
rs776625873 | 58 | A>V | No |
ExAC gnomAD |
|
rs1321356073 | 59 | H>P | No |
TOPMed gnomAD |
|
rs1810194256 | 59 | H>Q | No | Ensembl | |
rs1255003610 | 61 | H>N | No | gnomAD | |
rs746934075 | 61 | H>Q | No |
ExAC TOPMed gnomAD |
|
rs779946155 | 62 | G>C | No |
ExAC TOPMed gnomAD |
|
rs1353422098 | 62 | G>D | No |
TOPMed gnomAD |
|
rs779946155 | 62 | G>R | No |
ExAC TOPMed gnomAD |
|
rs779946155 | 62 | G>S | No |
ExAC TOPMed gnomAD |
|
rs1286870556 | 63 | I>F | No | gnomAD | |
rs1286870556 | 63 | I>V | No | gnomAD | |
rs926128321 | 66 | R>C | No |
TOPMed gnomAD |
|
rs745633361 | 67 | R>G | No |
ExAC TOPMed gnomAD |
|
rs778448883 | 67 | R>P | No |
ExAC TOPMed gnomAD |
|
rs778448883 | 67 | R>Q | No |
ExAC TOPMed gnomAD |
|
rs745633361 | 67 | R>W | No |
ExAC TOPMed gnomAD |
|
rs1384031505 | 70 | Y>N | No |
TOPMed gnomAD |
|
rs917482390 | 70 | Y>S | No | Ensembl | |
rs993260184 | 71 | C>G | No | Ensembl | |
rs1810193077 | 71 | C>Y | No | gnomAD | |
rs1421713806 | 72 | R>G | No |
TOPMed gnomAD |
|
rs753406405 | 72 | R>H | No |
ExAC TOPMed gnomAD |
|
rs753406405 | 72 | R>L | No |
ExAC TOPMed gnomAD |
|
rs1402401757 | 73 | T>A | No | gnomAD | |
rs1810192793 | 74 | G>A | No | TOPMed | |
rs1810192793 | 74 | G>D | No | TOPMed | |
rs1810192544 | 75 | F>L | No | TOPMed | |
rs1480681473 | 75 | F>S | No | gnomAD | |
rs1810192394 | 77 | L>P | No | TOPMed | |
rs1189147785 | 77 | L>V | No | gnomAD | |
rs112951749 | 78 | Q>E | No |
TOPMed gnomAD |
|
rs535724491 | 78 | Q>H | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs112951749 | 78 | Q>K | No |
TOPMed gnomAD |
|
rs1242227215 | 78 | Q>R | No | gnomAD | |
rs1266708845 | 79 | I>M | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA TOPMed gnomAD |
RCV000908702 rs377326763 |
79 | I>V | No |
ClinVar 1000Genomes ExAC TOPMed dbSNP gnomAD |
|
rs1810191840 | 80 | L>Q | No | Ensembl | |
rs1324785887 | 81 | P>H | No | gnomAD | |
rs1324785887 | 81 | P>R | No | gnomAD | |
rs1208644279 | 81 | P>S | No |
TOPMed gnomAD |
|
rs1208644279 | 81 | P>T | No |
TOPMed gnomAD |
|
rs1810191448 | 82 | D>E | No | TOPMed | |
rs1451460296 | 82 | D>N | No | gnomAD | |
rs553747126 | 83 | G>D | No |
1000Genomes ExAC gnomAD |
|
rs951419835 | 83 | G>R | No |
TOPMed gnomAD |
|
rs533886836 | 84 | S>N | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs1473311716 | 84 | S>R | No | gnomAD | |
rs533886836 | 84 | S>T | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs1415184585 | 85 | V>L | No | gnomAD | |
rs776748782 | 86 | Q>H | No |
ExAC gnomAD |
|
rs1270861983 | 86 | Q>R | No | gnomAD | |
TCGA novel | 87 | G>D | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs571418438 | 88 | T>A | No |
1000Genomes ExAC gnomAD |
|
rs760643638 | 88 | T>I | No |
ExAC gnomAD |
|
rs1228175652 | 89 | R>Q | No |
TOPMed gnomAD |
|
rs1408079162 | 89 | R>W | No | gnomAD | |
rs1173650694 | 90 | Q>* | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No |
NCI-TCGA gnomAD |
rs1203769902 | 90 | Q>H | No | gnomAD | |
rs1419715913 | 91 | D>E | No | gnomAD | |
rs1432260518 | 91 | D>N | No | gnomAD | |
rs771993864 | 92 | H>P | No |
ExAC TOPMed gnomAD |
|
rs1810190165 | 92 | H>Q | No | TOPMed | |
rs771993864 | 92 | H>R | No |
ExAC TOPMed gnomAD |
|
rs1187766235 | 92 | H>Y | No |
TOPMed gnomAD |
|
rs745659538 | 93 | S>G | No |
ExAC TOPMed gnomAD |
|
rs1208700823 | 93 | S>N | No | gnomAD | |
rs770778026 | 94 | L>I | No |
ExAC gnomAD |
|
rs1554495355 | 94 | L>R | No | Ensembl | |
rs777477639 | 95 | F>L | No |
ExAC gnomAD |
|
rs1274066944 | 96 | G>C | No |
TOPMed gnomAD |
|
rs1274066944 | 96 | G>R | No |
TOPMed gnomAD |
|
TCGA novel | 97 | I>M | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs370758961 | 98 | L>W | No |
ESP ExAC gnomAD |
|
rs774317326 | 99 | E>G | No |
ExAC gnomAD |
|
TCGA novel | 100 | F>C | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs1021365248 | 101 | I>V | No | TOPMed | |
rs1308905635 | 103 | V>M | No |
TOPMed gnomAD |
|
rs1810027774 | 104 | A>G | No | TOPMed | |
rs766380961 | 104 | A>S | No |
ExAC gnomAD |
|
rs1449412678 | 105 | V>M | No | TOPMed | |
rs1810027644 | 106 | G>R | No | Ensembl | |
COSM4919443 | 107 | L>M | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs766382683 | 107 | L>P | No |
ExAC gnomAD |
|
rs766382683 | 107 | L>Q | No |
ExAC gnomAD |
|
rs1162134925 | 108 | V>I | No |
TOPMed gnomAD |
|
rs1162134925 | 108 | V>L | No |
TOPMed gnomAD |
|
rs1376376754 | 109 | S>T | No | TOPMed | |
rs367661392 | 110 | I>V | No |
ESP ExAC TOPMed gnomAD |
|
rs769576140 | 111 | R>S | No |
ExAC gnomAD |
|
rs1810027190 | 112 | G>D | No | gnomAD | |
rs1292395727 | 112 | G>S | No | gnomAD | |
rs747822150 | 113 | V>M | No |
ExAC TOPMed gnomAD |
|
rs1161832443 | 114 | D>G | No | gnomAD | |
rs768178900 | 116 | G>D | No |
ExAC gnomAD |
|
RCV000912224 VAR_020946 rs3793405 |
116 | G>R | No |
ClinVar UniProt 1000Genomes ExAC TOPMed dbSNP gnomAD |
|
rs1810026731 | 117 | L>V | No | Ensembl | |
rs746460841 | 118 | Y>D | No |
ExAC gnomAD |
|
rs532205949 | 120 | G>A | No |
1000Genomes ExAC gnomAD |
|
rs1486159825 | 120 | G>R | No |
TOPMed gnomAD |
|
rs1328283813 | 121 | M>I | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA TOPMed gnomAD |
rs1283655289 | 122 | N>S | No | gnomAD | |
COSM232338 | 125 | G>E | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
COSM3646844 | 125 | G>R | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1040608226 | 125 | G>V | No |
TOPMed gnomAD |
|
rs563540999 | 127 | L>F | No |
1000Genomes ExAC gnomAD |
|
rs1810025981 | 127 | L>R | No | Ensembl | |
rs1323206170 | 130 | S>L | No | gnomAD | |
rs765043985 | 131 | E>D | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ExAC NCI-TCGA TOPMed gnomAD |
COSM3898467 | 133 | L>P | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
COSM3898466 | 133 | L>R | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs761688715 | 133 | L>V | No |
ExAC TOPMed gnomAD |
|
rs1323039427 | 134 | T>S | No | Ensembl | |
rs200152641 | 135 | S>C | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs200152641 | 135 | S>F | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs201317229 COSM174439 |
136 | E>K | Variant assessed as Somatic; MODERATE impact. large_intestine [NCI-TCGA, Cosmic] | No |
NCI-TCGA Cosmic cosmic curated ESP ExAC NCI-TCGA TOPMed gnomAD |
rs1450792723 | 137 | C>R | No | gnomAD | |
COSM6112877 | 138 | I>F | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1339121613 | 138 | I>M | No | gnomAD | |
rs1809959923 | 138 | I>V | No | Ensembl | |
rs775035654 | 139 | F>L | No |
ExAC gnomAD |
|
rs763495311 | 140 | R>G | No |
ExAC TOPMed gnomAD |
|
rs773742854 | 140 | R>K | No |
ExAC TOPMed gnomAD |
|
rs1306266506 | 140 | R>S | No | gnomAD | |
rs773742854 | 140 | R>T | No |
ExAC TOPMed gnomAD |
|
COSM3646843 | 141 | E>K | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1429266748 | 141 | E>Q | No |
TOPMed gnomAD |
|
COSM3367264 rs1385931006 |
142 | Q>E | kidney [Cosmic] | No |
cosmic curated gnomAD |
rs1336185318 | 142 | Q>H | No | TOPMed | |
rs1164980372 | 142 | Q>R | No | gnomAD | |
rs1563231817 | 144 | E>D | No | Ensembl | |
COSM181903 | 145 | E>D | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1209744626 | 148 | Y>C | No | TOPMed | |
COSM3898465 | 148 | Y>H | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1809958580 | 149 | N>I | No | gnomAD | |
rs770153930 | 149 | N>K | No |
ExAC gnomAD |
|
rs748560461 | 150 | T>S | No |
ExAC TOPMed gnomAD |
|
rs1249076606 | 153 | S>C | No | gnomAD | |
rs768990128 | 155 | I>R | No |
ExAC TOPMed gnomAD |
|
rs780320172 | 156 | Y>H | No |
ExAC TOPMed gnomAD |
|
rs750479279 | 157 | K>E | No |
ExAC TOPMed gnomAD |
|
rs1283992489 | 157 | K>N | No | gnomAD | |
rs1585100241 | 158 | H>L | No | Ensembl | |
rs1229326644 | 161 | T>A | No | gnomAD | |
rs757072657 | 161 | T>I | No |
ExAC gnomAD |
|
rs757072657 | 161 | T>N | No |
ExAC gnomAD |
|
rs143400495 | 162 | G>S | No |
ESP ExAC gnomAD |
|
COSM486240 rs1325559004 |
163 | R>C | kidney Variant assessed as Somatic; MODERATE impact. [Cosmic, NCI-TCGA] | No |
NCI-TCGA Cosmic cosmic curated NCI-TCGA TOPMed gnomAD |
rs1325559004 | 163 | R>G | No |
TOPMed gnomAD |
|
rs760365627 | 163 | R>H | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ExAC NCI-TCGA TOPMed gnomAD |
rs760365627 | 163 | R>L | No |
ExAC TOPMed gnomAD |
|
rs752318885 | 164 | R>K | No |
ExAC gnomAD |
|
rs767120553 | 164 | R>S | No |
ExAC TOPMed gnomAD |
|
rs1161426917 | 166 | F>L | No | TOPMed | |
rs759071753 | 166 | F>S | No |
ExAC gnomAD |
|
TCGA novel | 168 | A>H | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA |
rs1563231775 | 168 | A>V | No | TOPMed | |
rs1809957044 | 169 | L>F | No | TOPMed | |
rs773678490 | 170 | N>S | No |
ExAC gnomAD |
|
rs1809956855 | 171 | K>N | No | TOPMed | |
rs770340289 | 171 | K>R | No |
ExAC gnomAD |
|
rs762222483 | 172 | D>G | No |
ExAC TOPMed gnomAD |
|
rs762222483 | 172 | D>V | No |
ExAC TOPMed gnomAD |
|
rs1252960774 | 173 | G>R | No | gnomAD | |
rs1051138244 | 174 | T>A | No | Ensembl | |
VAR_020947 rs10089600 |
175 | P>A | No |
UniProt 1000Genomes ESP ExAC TOPMed dbSNP gnomAD |
|
rs772360437 | 175 | P>L | No |
ExAC TOPMed gnomAD |
|
rs772360437 | 175 | P>Q | No |
ExAC TOPMed gnomAD |
|
rs10089600 | 175 | P>T | No |
1000Genomes ESP ExAC TOPMed gnomAD |
|
COSM1699756 rs1809956313 |
176 | R>K | skin [Cosmic] | No |
cosmic curated TOPMed |
COSM3374838 | 177 | D>G | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1360206014 | 177 | D>H | No |
TOPMed gnomAD |
|
rs2150433589 | 178 | G>C | No | Ensembl | |
TCGA novel | 178 | G>D | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs376046538 | 179 | A>S | No |
ExAC TOPMed gnomAD |
|
rs376046538 | 179 | A>T | No |
ExAC TOPMed gnomAD |
|
rs749155129 | 180 | R>S | No |
ExAC TOPMed gnomAD |
|
rs921238581 | 181 | S>T | No | Ensembl | |
rs1809955799 COSM332163 |
182 | K>N | lung [Cosmic] | No |
cosmic curated gnomAD |
rs1368510325 | 182 | K>R | No | gnomAD | |
rs755939016 | 183 | R>G | No |
ExAC TOPMed gnomAD |
|
rs753990768 | 183 | R>K | No |
ExAC TOPMed gnomAD |
|
rs753990768 | 183 | R>M | No |
ExAC TOPMed gnomAD |
|
rs767173525 | 183 | R>S | No |
ExAC TOPMed gnomAD |
|
rs1809955393 | 184 | H>R | No | TOPMed | |
rs556236317 | 185 | Q>H | No |
1000Genomes ExAC gnomAD |
|
rs1809955191 | 188 | T>A | No |
TOPMed gnomAD |
|
rs1809955148 | 189 | H>D | No | Ensembl | |
rs1458723028 | 189 | H>Q | No | gnomAD | |
rs762432192 | 191 | L>F | No |
ExAC TOPMed gnomAD |
|
rs777035608 | 192 | P>A | No |
ExAC gnomAD |
|
rs1426756966 | 192 | P>R | No | gnomAD | |
rs764646776 | 194 | P>L | No |
ExAC gnomAD |
|
rs764646776 COSM1252411 |
194 | P>Q | oesophagus [Cosmic] | No |
cosmic curated ExAC gnomAD |
rs376283820 | 195 | V>E | No |
ESP ExAC TOPMed gnomAD |
|
rs1212546905 | 195 | V>L | No |
TOPMed gnomAD |
|
rs1809953511 | 197 | P>S | No | TOPMed | |
rs936045906 | 201 | P>S | No |
TOPMed gnomAD |
|
rs936045906 TCGA novel |
201 | P>T | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA TOPMed gnomAD |
rs1208432532 | 203 | L>M | No |
TOPMed gnomAD |
|
rs1281074178 | 204 | Y>C | No | gnomAD | |
rs372796901 | 204 | Y>H | No |
ESP ExAC TOPMed gnomAD |
|
rs774535729 | 205 | K>E | No |
ExAC gnomAD |
|
VAR_020948 RCV000965770 rs17550360 |
206 | D>N | No |
ClinVar UniProt 1000Genomes ESP ExAC TOPMed dbSNP gnomAD |
|
rs17550360 | 206 | D>Y | No |
1000Genomes ESP ExAC TOPMed gnomAD |
|
rs1365472443 | 208 | L>P | No |
TOPMed gnomAD |
|
rs747943357 | 209 | M>L | No |
ExAC TOPMed gnomAD |
|
rs1319650178 | 209 | M>R | No | gnomAD | |
rs747943357 | 209 | M>V | No |
ExAC TOPMed gnomAD |
|
rs780961429 | 210 | Y>H | No |
ExAC gnomAD |
|
rs573963889 | 211 | T>A | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs375846209 | 211 | T>N | No |
ESP ExAC TOPMed gnomAD |
|
rs573963889 | 211 | T>P | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs375846209 | 211 | T>S | No |
ESP ExAC TOPMed gnomAD |
|
rs1809952434 | 212 | T>S | No | TOPMed |
1 associated diseases with Q9NP95
[MIM: 615721]: Renal hypodysplasia/aplasia 2 (RHDA2)
A perinatally lethal renal disease encompassing a spectrum of kidney development defects, including renal agenesis, bilateral renal aplasia, hypoplasia, (cystic) dysplasia, and severe obstructive uropathy. . Note=The disease is caused by variants affecting the gene represented in this entry.
Without disease ID
- A perinatally lethal renal disease encompassing a spectrum of kidney development defects, including renal agenesis, bilateral renal aplasia, hypoplasia, (cystic) dysplasia, and severe obstructive uropathy. . Note=The disease is caused by variants affecting the gene represented in this entry.
7 regional properties for Q9NP95
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 217 - 485 | IPR000719 |
domain | SH2 domain | 112 - 205 | IPR000980 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 218 - 473 | IPR001245 |
active_site | Tyrosine-protein kinase, active site | 340 - 352 | IPR008266 |
binding_site | Protein kinase, ATP binding site | 223 - 250 | IPR017441 |
domain | Tyrosine-protein kinase, catalytic domain | 217 - 475 | IPR020635 |
domain | Fes/Fps/Fer, SH2 domain | 109 - 195 | IPR035849 |
3 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
extracellular region | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
5 GO annotations of molecular function
Name | Definition |
---|---|
fibroblast growth factor receptor binding | Binding to a fibroblast growth factor receptor (FGFR). |
growth factor activity | The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
heparan sulfate proteoglycan binding | Binding to a heparan sulfate proteoglycan, any proteoglycan containing heparan sulfate as the glycosaminoglycan carbohydrate unit. |
receptor-receptor interaction | The aggregation, arrangement and bonding together of two or more different receptor complexes that individually undergo combination with a hormone, neurotransmitter, drug or intracellular messenger to form a higher level receptor complex. The formation of the higher level complex initiates a change in cell function. |
signaling receptor binding | Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
15 GO annotations of biological process
Name | Definition |
---|---|
animal organ morphogenesis | Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. |
cell differentiation | The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
cell-cell signaling | Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
fibroblast growth factor receptor signaling pathway | The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands. |
inner ear auditory receptor cell differentiation | The process in which a relatively unspecialized inner cell acquires specialized features of an auditory hair cell. |
negative regulation of neuron apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. |
positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
positive regulation of dopaminergic neuron differentiation | Any process that activates or increases the frequency, rate or extent of dopaminergic neuron differentiation. |
positive regulation of ERK1 and ERK2 cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
positive regulation of protein phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
regulation of cardiac muscle cell proliferation | Any process that modulates the frequency, rate or extent of cardiac muscle cell proliferation. |
regulation of cell migration | Any process that modulates the frequency, rate or extent of cell migration. |
regulation of dopamine secretion | Any process that modulates the frequency, rate or extent of the regulated release of dopamine. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
28 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
P48801 | FGF3 | Fibroblast growth factor 3 | Gallus gallus (Chicken) | SS |
O15520 | FGF10 | Fibroblast growth factor 10 | Homo sapiens (Human) | SS |
O43320 | FGF16 | Fibroblast growth factor 16 | Homo sapiens (Human) | EV SS |
P10767 | FGF6 | Fibroblast growth factor 6 | Homo sapiens (Human) | SS |
P11487 | FGF3 | Fibroblast growth factor 3 | Homo sapiens (Human) | SS |
P31371 | FGF9 | Fibroblast growth factor 9 | Homo sapiens (Human) | EV |
Q92914 | FGF11 | Fibroblast growth factor 11 | Homo sapiens (Human) | SS |
Q9HCT0 | FGF22 | Fibroblast growth factor 22 | Homo sapiens (Human) | SS |
Q9NSA1 | FGF21 | Fibroblast growth factor 21 | Homo sapiens (Human) | PR |
P08620 | FGF4 | Fibroblast growth factor 4 | Homo sapiens (Human) | PR |
P21658 | Fgf6 | Fibroblast growth factor 6 | Mus musculus (Mouse) | SS |
Q9ESS2 | Fgf22 | Fibroblast growth factor 22 | Mus musculus (Mouse) | SS |
O35565 | Fgf10 | Fibroblast growth factor 10 | Mus musculus (Mouse) | SS |
P54130 | Fgf9 | Fibroblast growth factor 9 | Mus musculus (Mouse) | SS |
Q9JJN1 | Fgf21 | Fibroblast growth factor 21 | Mus musculus (Mouse) | PR |
Q9ESL8 | Fgf16 | Fibroblast growth factor 16 | Mus musculus (Mouse) | SS |
P11403 | Fgf4 | Fibroblast growth factor 4 | Mus musculus (Mouse) | PR |
P61329 | Fgf12 | Fibroblast growth factor 12 | Mus musculus (Mouse) | PR |
P05524 | Fgf3 | Fibroblast growth factor 3 | Mus musculus (Mouse) | SS |
Q9ESL9 | Fgf20 | Fibroblast growth factor 20 | Mus musculus (Mouse) | SS |
Q95L12 | FGF9 | Fibroblast growth factor 9 | Sus scrofa (Pig) | SS |
O54769 | Fgf16 | Fibroblast growth factor 16 | Rattus norvegicus (Rat) | SS |
P36364 | Fgf9 | Fibroblast growth factor 9 | Rattus norvegicus (Rat) | SS |
P70492 | Fgf10 | Fibroblast growth factor 10 | Rattus norvegicus (Rat) | SS |
Q9EST9 | Fgf20 | Fibroblast growth factor 20 | Rattus norvegicus (Rat) | SS |
Q6PBT8 | fgf1 | Putative fibroblast growth factor 1 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q2HXK8 | fgf16 | Fibroblast growth factor 16 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
P48802 | fgf3 | Fibroblast growth factor 3 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MAPLAEVGGF | LGGLEGLGQQ | VGSHFLLPPA | GERPPLLGER | RSAAERSARG | GPGAAQLAHL |
70 | 80 | 90 | 100 | 110 | 120 |
HGILRRRQLY | CRTGFHLQIL | PDGSVQGTRQ | DHSLFGILEF | ISVAVGLVSI | RGVDSGLYLG |
130 | 140 | 150 | 160 | 170 | 180 |
MNDKGELYGS | EKLTSECIFR | EQFEENWYNT | YSSNIYKHGD | TGRRYFVALN | KDGTPRDGAR |
190 | 200 | 210 | |||
SKRHQKFTHF | LPRPVDPERV | PELYKDLLMY | T |